Guided Therapeutics Net debt/EBITDA
Was ist das Net debt/EBITDA von Guided Therapeutics?
Net debt/EBITDA von Guided Therapeutics, Inc. ist -0.52
Was ist die Definition von Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA von Unternehmen in Health Care Sektor auf OTC im Vergleich zu Guided Therapeutics
Was macht Guided Therapeutics?
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Unternehmen mit net debt/ebitda ähnlich Guided Therapeutics
- Visteon hat Net debt/EBITDA von -0.52
- Bouvet ASA hat Net debt/EBITDA von -0.52
- TOT BIOPHARM International hat Net debt/EBITDA von -0.52
- Coolpad hat Net debt/EBITDA von -0.52
- Franchise International hat Net debt/EBITDA von -0.52
- Vanadiumcorp Resource hat Net debt/EBITDA von -0.52
- Guided Therapeutics hat Net debt/EBITDA von -0.52
- Mandalay Resources hat Net debt/EBITDA von -0.52
- Midnight Sun Mining hat Net debt/EBITDA von -0.51
- Sonoro Gold hat Net debt/EBITDA von -0.51
- McEwen Mining hat Net debt/EBITDA von -0.51
- SKY Network Television hat Net debt/EBITDA von -0.51
- Old Dominion Freight Line hat Net debt/EBITDA von -0.51